These success, together with a earlier report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the thought of concentrating on ACKR3 as a singular solution to modulate the opioid method, which could open up new therapeutic avenues fo